StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Incyte Corporation
NasdaqGS:INCY
Sector
Industries
Location
Market Cap
USD 13.20 B
Share Price
USD 68.17
Avg Daily Volume
2,092,220
Change (1 day)
-0.81%
Change (1 year)
15.50%
Change (YTD)
-1.30%
Incyte Corporation Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 21.75
Incyte Corporation Revenue Per Share is USD 21.75 for the Trailing 12 Months (TTM) ending March 31, 2025, a 29.31% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Incyte Corporation Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 16.82, a 7.81% change year over year.
-
Incyte Corporation Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 15.60, a 10.60% change year over year.
-
Incyte Corporation Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 14.11, a 14.00% change year over year.
-
Incyte Corporation Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 12.37, a 19.60% change year over year.
Competitors
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Thermo Fisher Scientific Inc.
USD 427.76
TMO
+6.29
1.49%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Boston Scientific Corporation
USD 103.63
BSX
-1.15
-1.10%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
CSL Limited
USD 159.11
CSL.AX
+1.27
0.80%
Siemens Healthineers AG
USD 55.95
SHL.DE
+0.55
1.00%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Thermo Fisher Scientific Inc.
USD 427.76
TMO
+6.29
1.49%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Boston Scientific Corporation
USD 103.63
BSX
-1.15
-1.10%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
CSL Limited
USD 159.11
CSL.AX
+1.27
0.80%
Siemens Healthineers AG
USD 55.95
SHL.DE
+0.55
1.00%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%